Quince Therapeutics
QNCX
QNCX
42 hedge funds and large institutions have $8.4M invested in Quince Therapeutics in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
38% less capital invested
Capital invested by funds: $13.5M → $8.4M (-$5.11M)
Holders
42
Holding in Top 10
–
Calls
$87K
Puts
–
Top Buyers
| 1 | +$93.5K | |
| 2 | +$85K | |
| 3 | +$84.1K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$63.5K |
| 5 |
Renaissance Technologies
New York
|
+$40.7K |
Top Sellers
| 1 | -$2.12M | |
| 2 | -$344K | |
| 3 | -$128K | |
| 4 |
Two Sigma Advisers
New York
|
-$66.4K |
| 5 |
Two Sigma Investments
New York
|
-$55.9K |